Market Overview

UPDATE: Pritchard Capital Partners Downgrades Endeavour International; Lowers PT

Share:

According to a research report published this morning, Pritchard Capital Partners has downgraded Endeavour International (NYSE: END) from Buy to Neutral, and lowers PT from $17 to $10.

In the report, Pritchard Capital Partners said, "Discussions continue between ConocoPhillips (COP, $54.59-NR) and the Alba partners, including the operator, Chevron Corporation (CVX, $107.03-NR), concerning the closing requirements for the Alba field transaction. While END believes progress is being made and the deal can close by the end of this month, we would rather move to the sidelines until the situation is resolved and are downgrading the stock. Based on this new development, we believe it is necessary to exercise caution, and are removing the acquisition from our numbers and reducing our NAV and PT to $13 and $10 from $21 and $17."

Endeavour International closed yesterday at $9.77.

Posted-In: Pritchard Capital PartnersAnalyst Color Downgrades Price Target Analyst Ratings

 

Related Articles (END)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
AAPLWedbushInitiates Coverage On310.0
DHTJP MorganUpgrades0.0
DISBarclaysUpgrades130.0
DXCMGoldman SachsUpgrades125.0
ORLYJP MorganUpgrades398.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Deutsche Bank Raises PT to $8 on Capital Product Partners

UPDATE: Canaccord Genuity Lowers STAAR Surgical Company's PT